Results 71 to 80 of about 27,638 (211)
Abstract Objective To describe the procedure and short‐term outcomes of two dogs that underwent laparoscopic stapled partial cystectomy with intraoperative cystoscopy for excision of solitary, non‐trigonal, urothelial carcinoma lesions. Animals A 12‐year‐old female spayed mixed breed and a 13‐year‐old female spayed Siberian Husky.
Maureen A. Griffin +2 more
wiley +1 more source
Laparoscopic radical cystectomy
Laparoscopic radical cystectomy (LRC) has emerged as a minimally invasive alternative to open radical cystectomy (ORC). This review focuses on patient selection criteria, technical aspects and postoperative outcomes of LRC.Material for the review was obtained by a PubMed search over the last 10 years, using the keywords 'laparoscopic radical cystectomy'
openaire +2 more sources
Abstract Two entire female dwarf rabbits (Oryctolagus cuniculus), aged 5 months and 10 years, were presented with a mass protruding from the vaginal opening. Diagnostic imaging and exploratory laparotomy confirmed the diagnosis of transurethral urinary bladder eversion. Both animals were treated successfully by surgical intervention.
Kerstin Müller, Christine Rutz
wiley +1 more source
Robotic-assisted laparoscopic radical cystectomy: surgical and oncological outcomes
PURPOSE:Our first 91 consecutive cases undergoing a robotic assisted cystectomy were analyzed regarding perioperative outcomes, pathological stages and surgical complications.
Adrian Treiyer +5 more
doaj +1 more source
ABSTRACT The high demand for cystoscopies performed for bladder cancer diagnosis or surveillance imposes a significant burden on regional centres with limited capacity. Cxbladder is a urinary biomarker test that estimates the likelihood of bladder cancer.
Claris Oh +4 more
wiley +1 more source
Robot-Assisted Radical Cystectomy Using the Hinotori Surgical System in Patients With Previous Prostate Cancer Treatment: A Single-Institution Case Series. [PDF]
International Journal of Urology, Volume 33, Issue 3, March 2026.
Uchida K +5 more
europepmc +2 more sources
SUBDUE‐3: SUB‐urothelial DUrvalumab‐89zirconium injEction; a phase 0 biodistribution study protocol
BJU International, EarlyView.
Kevin G. Keane +9 more
wiley +1 more source
What's new? New antibody‐drug conjugates (ADCs) and immunotherapies have helped expand treatment options for urothelial carcinoma (UC). Clinical trials suggest that the ADC enfortumab vedotin (EV) and the immunotherapeutic agent pembrolizumab, when used in combination, are especially effective against UC.
Dora Niedersuess‐Beke +30 more
wiley +1 more source
Aligning bladder cancer research with patient needs: an update on research priorities
BJU International, EarlyView.
Nada Humayun‐Zakaria +3 more
wiley +1 more source

